Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2020

Dec 18, 2020

33193_dirs_2020-12-17_bf07b375-77e6-4405-93dd-c40329ff875d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2020-12-15

Reporting Person: Rhodes Jason P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-15 Common Stock S 28078 $42.40 Disposed 2283960 Indirect
2020-12-15 Common Stock S 349 $43.12 Disposed 2283611 Indirect
2020-12-15 Common Stock S 70 $44.08 Disposed 2283541 Indirect
2020-12-15 Common Stock S 9710 $42.40 Disposed 958589 Indirect
2020-12-15 Common Stock S 120 $43.12 Disposed 958469 Indirect
2020-12-15 Common Stock S 24 $44.08 Disposed 958445 Indirect
2020-12-15 Common Stock S 2432 $42.40 Disposed 21049 Indirect
2020-12-15 Common Stock S 30 $43.12 Disposed 21019 Indirect
2020-12-15 Common Stock S 6 $44.08 Disposed 21013 Indirect
2020-12-16 Common Stock S 8849 $42.13 Disposed 2274692 Indirect
2020-12-16 Common Stock S 3060 $42.13 Disposed 955385 Indirect
2020-12-16 Common Stock S 766 $42.13 Disposed 20247 Indirect
2020-12-17 Common Stock S 8053 $42.00 Disposed 2266639 Indirect
2020-12-17 Common Stock S 2785 $42.00 Disposed 952600 Indirect
2020-12-17 Common Stock S 697 $42.00 Disposed 19550 Indirect

Footnotes

F1: Shares were sold pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.975 to $42.97 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (7) and (8).

F3: The shares are held directly by Atlas Venture Fund X, L.P. ("Atlas Venture Fund X"). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. ("AVA X LP"). Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.44 inclusive.

F5: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. The Reporting Person is a member of AVAO I LLC and disclaims beneficial ownership of such securities held by Atlas Venture Opportunity Fund I, except to the extent of his pecuniary interest therein, if any.

F6: The shares are held directly by AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims beneficial ownership of such securities held by AVA X LP, except to the extent of his pecuniary interest therein, if any.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.95 to $42.80 inclusive.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.95 to $42.37 inclusive.